• loading
  • +44 (0)20 8762 8008
  • Change Language
    [Close]
      • Language English
      • Language Japanese
      LanguageEnglish
  • Home
  • Overview
    • Pandemic
    • Bird Flu
  • Subscribers
    • Overview
    • References
    • Planning Tools
    • Travel Advice
    • Email Sign up
  • Locations
  • Newsroom
    • News
    • Editorials
    • FAQs

Quick Links

  • Home
  • About Us
  • Careers
  • CSR
  • Foundation
International SOS Logo
View Map
  • +44 (0)20 8762 8008 Call for Assistance
    • Language English
    • Language Japanese
    LanguageEnglish
  • Search
  • loading
    Log In
  • Home
  • Overview
    • Pandemic
    • Bird Flu
  • Subscribers
    • References
    • Planning Tools
    • Travel Advice
    • Email Sign up
  • Locations
  • Newsroom
    • News
    • Editorials
    • FAQs
  • About Us
  • Careers
  • CSR
  • Foundation
  • Pandemic Preparedness
  • 2019-nCoV
Print

COVID-19

 


Public Access

Interactive COVID-19 Data by Location

COVID-19 Case Count Trackers

Education and Communication

COVID-19 FAQs and External Resources

COVID-19 Videos

 

 

 

Member Access

 

Travel Restrictions, Flight Operations and Screening

Digital Passports

COVID-19 Digital Passports


Scientific Update

COVID-19 FAQs

COVID-19 Vaccine

COVID19 Vaccine FAQs

COVID-19 Vaccine FAQs

Variant

COVID-19 Variants

COVID-19 Testing

COVID-19 Treatment

Use of Face Masks by the General Public

COVID-19 Travel Advice


 

COVID-19 Disease and Prevention Article


Sign up for Emails and Alerts

 

Premium Services Member Access

 

 

 

COVID-19 Manager Advice


 

COVID-19 Case Definitions used by different authorities

Impact Tool

Pandemic Local Impact Tool

COVID-19 Communication Material


 

COVID modelling with R0 equations

COVID-19 Modelling

COVID-19 Useful Links


 

HOT TOPICS (PREMIUM ACCESS)

  1. …
  2. 15
  3. 16
  4. 17
  5. 18
  6. 19
  7. …
  • Fluvoxamine and reduced COVID-19 hospitalisation, study

    09 April, 2022

    A systematic review and meta-analysis published on JAMA Network...

    COVID-19

  • Risks of developing deep vein thrombosis, pulmonary embolism and bleeding after COVID-19, study

    Sweden // 09 April, 2022

    A study published in the BMJ...

    COVID-19

  • FDA no longer authorises use of sotrovimab

    United States // 08 April, 2022

    In any US state and territory...

    COVID-19

  • Protection by fourth dose of Pfizer vaccine, study

    08 April, 2022

    Rates of COVID-19 infection lowered...

    COVID-19

  • Periodic booster dose of COVID-19 vaccine approved

    Bahrain // 08 April, 2022

    All vaccinated adults are eligible to take a dose of COVID-19 vaccine every nine months from...

    COVID-19

  • New IMF strategy to manage the long-term risks of COVID-19

    08 April, 2022

    The International Monetary Fund released its Global Strategy for the management of COVID-19...

    COVID-19

  • WHO: Close to two-thirds of people in Africa exposed to COVID-19

    08 April, 2022

    COVID-19 infections in Africa are estimated to be 97 times higher than reported...

    COVID-19

  • WHO suspends Covaxin supply

    06 April, 2022

    The World Health Organization (WHO) has suspended the supply of Bharat Biotech’s COVID-19 vaccine, Covaxin through...

    COVID-19

  • WHO lists country medicines regulators that meet standards

    Nigeria // Egypt // 04 April, 2022

    Egypt and Nigeria achieve "Maturity Level 3". Transitional list comes into effect later in 2022....

    COVID-19

  • Vaccine Update - Fourth dose approved

    Germany // 04 April, 2022

    Updates on vaccination in Germany...

    COVID-19

  • All residents requested to voluntary test for COVID-19 from 8 to 10 April

    Hong Kong (China SAR) // 02 April, 2022

    Officials announce 3-day self-test exercise…..

    COVID-19

  • COVID-19 Update – Surge in cases and state of emergency

    American Samoa // 01 April, 2022

    Cases have surged and authorities have declared a State of Emergency...

    COVID-19

  • CDC updates booster dose guidelines following FDA authorisation

    United States // 01 April, 2022

    Following authorisation by the FDA, CDC has updated guidelines for booster doses...

    COVID-19

  • One stop shop launched

    United States // 31 March, 2022

    All resources for COVID-19 in one place…

    COVID-19

  • WHO issues guidance on digitally documenting COVID-19 test results

    31 March, 2022

    WHO guidance for digital test documentation...

    COVID-19

  • Study: Ivermectin not a viable treatment for COVID-19

    31 March, 2022

    Ivermectin is not viable for the treatment of COVID-19

    COVID-19

  • Contact Investigation and contact tracing may help control COVID-19

    United States // 30 March, 2022

    CICT programs are critical to control spread of COVID-19

    COVID-19

  • COVID-19 in animals in the United States

    United States // 29 March, 2022

    Several animal species have been confirmed to have SARS-CoV-2 across the United States...

    COVID-19

  • WHO COVID-19 Weekly Reports, March 2022

    29 March, 2022

    WHO released their weekly update on COVID-19...

    COVID-19

  • Immune response may persist until 12 months after initial infection

    27 March, 2022

    Antibody response against COVID-19 after a year.

    COVID-19

  1. …
  2. 15
  3. 16
  4. 17
  5. 18
  6. 19
  7. …
  • Pandemic Home
  • Privacy
  • Contact Us
  • Feedback
  • Terms and Conditions
Footer Image


GeoNames logo

Additional data provided by

© 2024 International SOS